Jaminelli Banks, DPM
Foot & Ankle Surgery · Phoenix, AZNPI 1184160517
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.0%), education and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Arthrex at 29.1% of the total. Reporting peaked in 2021 at $2,598 and has fallen 71.9% since, to $731 in 2025.
Across 96 payments — averaging $71.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Impactortho, Inc.$1K
- Kerecis Limited$729
- AbbVie$654
- Stryker$506
- Nevro Corp.$468
- plus $1K from 16 others
Across 19 payments — averaging $50,881 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Organogenesis Inc.$888K
- Convatec Inc.$79K
What the payments were for
- Travel & lodging$4426%
- Food & beverage$3,68054%
- Education$2,69740%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 10 | $1,983 |
| Impactortho, Inc. | 1 | $1,200 |
| Kerecis Limited | 8 | $729 |
| AbbVie | 33 | $654 |
| Stryker | 8 | $506 |
| Nevro Corp. | 6 | $468 |
| Medtronic | 2 | $183 |
| Smith+Nephew | 5 | $172 |
| Paratek Pharmaceuticals, Inc. | 4 | $163 |
| Organogenesis Inc. | 3 | $132 |
| Acera Surgical, Inc. | 1 | $127 |
| Amgen | 1 | $124 |
| Tactile Systems Technology Inc | 1 | $104 |
| Bioventus LLC | 2 | $59 |
| Integra Lifesciences Corporation | 2 | $48 |
| Advanced Oxygen Therapy Inc. | 3 | $48 |
| Zimmer Biomet | 1 | $30 |
| Surgenex LLC | 1 | $29 |
| Tenex Health Inc. | 1 | $17 |
| Illuminoss Medical, Inc. | 1 | $16 |
| International Rehabilitative Sciences, Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$773
- Kerecis Omega3 GraftGuide$526
- Kerecis Omega3 SurgiClose$526
- Kerecis SurgiClose$443
- Kerecis Omega3 Wound$269
- Kerecis Omega3 Surgibind$269
- TurboHawk$154
- T2$139
- Restrata Wound Matrix$127
- NUZYRA$125
- KRYSTEXXA$124
- Kerecis GraftGuide$111
- FLEXITOUCH$104
- ACTITOUCH$104
- ENTRE$104
How this compares
$6,818 in reported general payments places this provider in the 70th percentile of 291 foot & ankle surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other foot & ankle surgery in Phoenix
- Ryan ScottPhoenix$1.1M
- Jeffrey HolmesPhoenix$509K
- Melissa GalliPhoenix$324K
- Zachary FlynnPhoenix$239K
- Kyle VaughnPhoenix$110K
- David JaffePhoenix$75K
- Jason KaycePhoenix$57K
- Devin BlandPhoenix$49K
- Braden BoyerPhoenix$32K
- Martin WeismanPhoenix$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.